SandipMPrasadMDMPhil

Urology • Morristown, NJ

Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Director of Genitourinary Surgical Oncology, Morristown Medical Center Vice-Chair of Urology, Morristown Medical Center

Join to view full profile

Dr. Prasad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Prasad's full profile

Already have an account?

Office
261 James Street
Suite 2G
Morristown, NJ 07960
Phone+1 973-539-0333

Summary

Dr. Sandip Prasad is an urologist in Morristown, NJ and is affiliated with Morristown Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 12 years. He specializes in minimally invasive surgery, stone disease, and surgical oncology and is experienced in prostate cancer, gynecologic oncology, urologic oncology, minimally invasive urologic surgery, and urologic trauma and reconstructive surgery.

Education & Training

Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2010
Brigham and Womens HospitalInternship, Transitional Year, 2005 - 2006
Duke University School of MedicineClass of 2005
University of CambridgeMphil, Epidemiology, With Distinction, 1998 - 1999
Harvard UniversityA.B., Environmental Science and Public Policy, Magna cum laude, 1994 - 1998

Certifications & Licensure

NJ State Medical License 2017 - 2025
SC State Medical License 2012 - 2017
IL State Medical License 2010 - 2014
MA State Medical License 2008 - 2010
American Board of Urology Urology

Awards, Honors, & Recognition

Merit Award ASCO Cancer Foundation, 2010
Outstanding poster presentation American Urological Association, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Travel Award Global Health Initiative International, 2011
John Quale Travel Fellowship Award for Young Investigators Bladder Cancer Advocacy Network Annual Think Tank Meeting, 2011
Traveling Fellowship Award North Central Section of the American Urological Association, 2011
Gerald P. Murphy Scholar AUA, 2010
Clinical and Translational Science Award Core Subsidy for Biostatistics University of Chicago Institute for Translational Medicine, 2010
Medical Student Teaching Award Harvard Medical School, 2006
Outstanding Oral Presentation Duke University School of Medicine, 2004
William G. Anlyan Senior Scholarship Duke University School of Medicine, 2004
3rd place, Oral Presentation Washington University, 2004
Alpha Omega Alpha 2004
Research Training Fellowship Howard Hughes Medical Institute, 2003
The Engel Society Duke University School of Medicine, 2002
Scholar Blackwell Scholars Program, 2002
Cambridge Overseas Trust Scholarship University of Cambridge, 1998
John Harvard Scholarship Harvard University, 1996
Harvard College Scholar Harvard University, 1994
Academy of Achievement 1994
National Merit Scholarship 1994
Finalist, Presidential Scholars Program 1994
Join now to see all

Clinical Trials

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2013 Oct 14
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION).
Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, Alexandre Khuskivadze, Pencho Genov
The Journal of Urology. 2024-10-24
Primary Chemoablation for Intermediate-Risk Low-Grade Bladder Cancer: New Paradigm or Added Uncertainty? Letter.
Sandip M Prasad
The Journal of Urology. 2023-12-01
Editorial Comment.
Gabriel Fernandez, Sandip M Prasad
Urology Practice. 2023-11-01

Journal Articles

Early discharge after laparoscopic or robotic partial nephrectomy: care pathway evaluation
Patel A, Golan S, Razmaria A, Prasad S, Eggener S, Shalhav A, British Journal of Urology International, 1/1/2014
Does robotic-assisted laparoscopic ileocystoplasty (RALI) reduce peritoneal adhesions compared to open surgery
Razmaria AA, Marchetti PE, Prasad SM, Shalhav AL, Gundeti MS, British Journal of Urology International, 1/1/2014
Ultrasonography in prostate cancer: current roles and potential applications in radiorecurrent disease
Rosoff JS, Prasad SM, Savage SJ, World Journal of Urology, 1/1/2013
Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications
Rosoff JS, Savage SJ, Prasad SM, World Journal of Urology, 1/1/2013
Morbidity and costs of salvage versus primary radical prostatectomy in older men
Prasad SM, Gu X, Kowalczyk KJ, Lipsitz SR, Nguyen PL, Hu JC, Urologic Oncology: Seminars and Original Investigations, 1/1/2013
Salvage combination intravesical immunotherapy with bacillus calmette-guerin and interferon-a2 Beta: impact on recurrence, progression and survival
Prasad SM, Eyre S, Loughlin KR, Hospital Practice, 1/1/2013
Finishing the picture: problems with public reporting of clinical trials
Prasad SM, Bennett CL, Journal of Clinical Oncology, 1/1/2013
Long-term differences in urinary, bowel and sexual function among men treated with surgery versus radiation for prostate cancer
Ellett JD, Rosoff JS, Prasad SM, Asian Journal of Andrology, 1/1/2013
Suprapubic tube after radical prostatectomy
Prasad SM, Smith ND, Catalona WJ, Sammon J, Menon M, Journal of Urology, 1/1/2013
Comparative effectiveness of minimally-invasive versus open lymphadenectomy in urological cancers
Prasad SM, Shalhav AS, Current Opinion in Urology, 1/1/2013
Bladder cancer risk from occupational and environmental exposures
Kiriluk K, Prasad SM, Patel AR, Steinberg GD, Smith ND, Urologic Oncology: Seminars and Original Investigations, 1/1/2012
The impact of mechanical bowel preparation on postoperative complications for patients undergoing cystectomy and urinary diversion
Large MC, Kiriluk KJ, Decastro GJ, Patel AR, Prasad S, Jayram G, Weber SG, Steinberg GD, Journal of Urology, 1/1/2012
The association of human development index and global kidney cancer incidence and mortality
Patel AR, Prasad SM, Shih Y-AT, Eggener SE, Journal of Urology, 1/1/2012
Factors associated with the adoption of minimally-invasive radical prostatectomy in the United States
Ulmer WD, Prasad SM, Kowalczyk KJ, Gu X, Dodgion C, Lipsitz SR, Palapattu GS, Choueiri TK, Hu JC, Journal of Urology, 1/1/2012
2008 United States Preventive Services Task Force recommendations and prostate cancer screening rates
Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE, Journal of the American Medical Association, 1/1/2012
High-risk urothelial carcinoma of the bladder: definition, treatment and future efforts
Prasad SM, DeCastro GJ, Steinberg GD, Nature Reviews Urology, 1/1/2011
Trends in the care of radical prostatectomy in the United States from 2003-2006
Williams SB, Prasad SM, Weinberg AC, Shelton J, Hevelone ND, Lipsitz SR, Hu JC, British Journal of Urology International, 1/1/2011
From prostate to bone: key players in prostate cancer bone metastasis
Thobe MN, Clark RJ, Bainer RO, Prasad SM, Rinker-Schaeffer CW, Cancers, 1/1/2011
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy
Prasad SM, Gu X, Lavelle R, Lipsitz SR, Weinberg AC, Choi W, Hu JC, Journal of Urology, 1/1/2011
Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer
Prasad MM, Prasad SM, Hevelone ND, Gu X, Weinberg AC, Lipsitz SR, Palapattu GS, Hu JC, Journal of Sexual Medicine, 1/1/2010
Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes
Freire MP, Weinberg AC, Yei Y, Soukup JR, Lipsitz SR, Prasad SM, Korkes F, Lin T, Hu JC, European Urology, 1/1/2009
Surgical Apgar outcomes score: perioperative risk assessment for radical cystectomy
Prasad SM, Ferreria M, Berry AM, Lipsitz SR, Richie JR, Gawande AA, Hu JC, Journal of Urology, 1/1/2009
Variations in radical prostatectomy surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy
Prasad SM, Keating NL, Wang Q, Pashos CL, Lipsitz S, Richie JP, Hu JC, Urology, 1/1/2008
Microwave ablation for atrial fibrillation: dose response curves in the cardioplegia-arrested and beating heart
Gaynor SL, Byrd GD, Diodato MD, Ishii Y, Lee AM, Prasad SM, Gopal J, Schuessler RB, Damiano RJ, Annals of Thoracic Surgery, 1/1/2006
Hyperkalemic cardioplegia-induced myocyte swelling and contractile dysfunction: prevention by diazoxide
Mizutani S, Al-Dadah AS, Bloch JB, Prasad SM, Diodato MD, Schuessler RB, Damiano RJ, Lawton JS, Annals of Thoracic Surgery, 1/1/2006
Join now to see all

Press Mentions

ENVISION Trial Results Published in the Journal of Urology Report 82.3% Duration of Response 12 Months After Achieving Complete Response for UGN-102, Potentially First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBCOctober 28th, 2024
7 Studies at American Society of Clinical Oncology (ASCO) Annual Meeting Presented by Atlantic Health System Cancer Care Physician ResearchersJune 7th, 2021
Prostate Cancer ADT Found to Increase Depression RiskApril 22nd, 2019
Join now to see all